Novo Nordisk Full Year 2023 Investor Presentation

Novo Nordisk's full year 2023 investor presentation outlining progress on strategic aspirations, financial results, innovation initiatives, and commercial execution. The healthcare company focuses on therapeutic areas including obesity treatment and diabetes management with products such as Wegovy, Ozempic, and Saxenda.